Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- L. Miele, V. Valenza, A. Grieco
- Medicine, BiologyHepatology
- 1 June 2009
TLDR
European consensus conference on faecal microbiota transplantation in clinical practice
- G. Cammarota, G. Ianiro, A. Gasbarrini
- MedicineGut
- 13 January 2017
TLDR
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
- M. Zocco, E. di Stasio, A. Gasbarrini
- MedicineJournal of hepatology
- 1 October 2009
Methodology and Indications of H2‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference
- A. Gasbarrini, G. Corazza, A. Tursi
- MedicineAlimentary pharmacology & therapeutics
- 30 March 2009
TLDR
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study
- G. Addolorato, L. Leggio, G. Gasbarrini
- MedicineThe Lancet
- 8 December 2007
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori
- A. Gasbarrini, F. Franceschi, R. Tartaglione, R. Landolfi, P. Pola, G. Gasbarrini
- Medicine, BiologyThe Lancet
- 12 September 1998
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
- M. Zocco, L. Z. Dal Verme, A. Gasbarrini
- MedicineAlimentary pharmacology & therapeutics
- 1 June 2006
Aminosalicylates are the mainstay of therapy to prevent relapse of quiescent ulcerative colitis. The rationale for using probiotics is based on the evidence implicating intestinal bacteria in the…
Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
- G. Addolorato, F. Caputo, G. Gasbarrini
- MedicineAlcohol and alcoholism
- 1 September 2002
TLDR
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
- G. Addolorato, F. Caputo, E. Capristo, G. Colombo, G. Gessa, G. Gasbarrini
- MedicineAlcoholism, clinical and experimental research
- 2000
TLDR
Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study
- F. Cremonini, S. Caro, A. Gasbarrini
- MedicineAmerican Journal of Gastroenterology
- 1 November 2002
TLDR
...
...